November 2, 2016
Kite Pharma today announced that it will report third quarter 2016 financial results on Wednesday, November 9, 2016, prior to...
October 11, 2016
A look at immuno-oncology.
September 13, 2016
Biotech has been beset in recent months: negative media coverage, the American election, and some disappointing clinical trial results contributed...
July 10, 2016
Loncar Investments founder, independent biotech investor and analyst Brad Loncar comments on the biggest trends in the cancer immunotherapy space.
July 4, 2016
An exclusive interview with Loncar Investments founder, independent biotech investor and analyst Brad Loncar.
June 13, 2016
SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc., (AIS), a privately held biotechnology company developing a next-generation immune system modulation platform, today announced...
July 29, 2015
NantKwest hit the stock market on Tuesday with an initial public offering hat values the company at $2.6 billion.